- Report
- December 2022
- 161 Pages
From €3096EUR$3,450USD£2,664GBP
- Report
- December 2022
- 181 Pages
Asia Pacific
From €3096EUR$3,450USD£2,664GBP
- Report
- December 2022
- 186 Pages
Europe
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2022
- 163 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- January 2022
- 209 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- August 2021
- 119 Pages
Asia Pacific
From €3096EUR$3,450USD£2,664GBP
- Report
- September 2020
- 76 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4442EUR$4,950USD£3,823GBP
- Report
- September 2022
- 115 Pages
Global
From €6730EUR$7,500USD£5,792GBP
- Report
- September 2022
- 62 Pages
Global
From €3544EUR$3,950USD£3,050GBP
- Report
- January 2022
- 60 Pages
Global
From €3544EUR$3,950USD£3,050GBP
- Report
- January 2022
- 60 Pages
Global
From €3544EUR$3,950USD£3,050GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1122EUR$1,250USD£965GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more